language_icon
EN
HI

Eris Lifesciences Share price

ERIS

1353.6

30.70 (2.32%)
NSE
BSE
Last updated on 4 May, 2026 | 15:31 IST
Today's High

1356.50

Today's Low

1322.90

52 Week Low

1200.00

52 Week High

1910.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Eris Lifesciences Chart

Eris Lifesciences Share Key Metrics

Volume
37205.00
Market Cap
18753.17 CR
LTQ@LTP
4@1353.60
ATP
1349.89
Var Margin
16.02 %
Circuit Range
1058.4-1587.4
Delivery %
76.93 %
Value
5.02 CR
ASM/GSM
No
Market Lot
1

Summary

4 May, 2026 | 15:31 को, Eris Lifesciences का शेयर प्राइस आज ₹1353.6 पर है, जो दिन के लिए 30.70% की 2.32 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1322.90 और ₹1356.50 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1200.00 से ₹1910.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Eris Lifesciences ने 37205 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹138542887 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹134989 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 4,135360 रही। यह स्टॉक ₹1058.4-1587.4 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹5.02 CR है। दिन के लिए डिलीवरी परसेंटेज 76.93% रही। इसके अतिरिक्त, Eris Lifesciences वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Eris Lifesciences Fundamentals

View More
P/E Ratio

42.45

P/B Ratio

5.06

Div. Yield

0.56

Sector P/E

51.38

Sector P/B

3.49

Sec. Div. Yield

0.57

Eris Lifesciences Resistance and Support

Pivot 1322.7

Resistance

First Resistance

1337.4

Second Resistance

1351.9

Third Resistance

1366.6

Support

First Support

1308.2

Second Support

1293.5

Third Support

1279

Eris Lifesciences Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

54.86%

Mutual Fund

16.52%

Insurance

0.74%

Foreign Institutional Investors

8.36%

Domestic Institutional Investors

0.79%

Retail

18.72%

Others

0.01%

Total Promoters
MAR '24
54.9%
JUN '24
54.88%
SEP '24
54.87%
DEC '24
54.86%

Eris Lifesciences Corporate Actions

DateAgenda
2026-02-13Quarterly Results

Eris Lifesciences News

Eris Lifesciences Limited

Eris Lifesciences announced a postal ballot for the appointment of Mr. Vineet Varma as an Independent Director. His tenure is proposed for five years, from March 14, 2026, to March 13, 2031, with voting concluding on March 23, 2026.
Apr 23 2026 17:04:00

Eris Lifesciences Limited

Eris Lifesciences seeks shareholder approval via postal ballot to appoint Mr. Vineet Varma as an Independent Director for five years. The e-voting period commences on April 24, 2026, and concludes on May 23, 2026.
Apr 23 2026 17:04:00

Eris Lifesciences shares decline nearly 6% after observations issued for Swiss facilities

Eris Lifesciences' manufacturing facilities in Switzerland have received observations from the Croatian health regulator following an impact inspection, indicating potential compliance issues.
Apr 21 2026 15:04:00

Eris Lifesciences Limited

Eris Lifesciences' Swiss Parenterals units 1 & 2 received non-compliance observations from HALMED after a March 9-13, 2026 inspection. The company will address these procedural issues to reinstate approvals and ensure GMP compliance, though it might delay EU-CDMO product commercialization.
Apr 20 2026 22:04:00
Read More

About Eris Lifesciences AboutThe

NSE : 21154  
BSE : 540596  
ISIN : INE406M01024  

The Company was incorporated as “Eris Lifescience Private Limited” on January 25 2007 as a private limited company under the Companies Act 1956 at Ahmedabad with a certificate of incorporation granted by the Registrar of Companies Gujarat Dadra and Nagar Haveli. Pursuant to a resolution of the Shareholders dated February 5 2007 the name of the Company was changed to “Eris Lifesciences Private Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies Gujarat Dadra and Nagar Haveli on February 9 2007. Further pursuant to a conversion of the Company to a public limited company and as approved by the Shareholders through a resolution dated January 31 2017 the name was changed to “Eris Lifesciences Limited” and the RoC issued a fresh certificate of incorporation on February 2 2017.Major events and milestonesThe table below sets forth some of the major events in the history of the Company.2007-Incorporation of the Company-Launched “Eris” division focused on cardiology and diabetes segment2008-Launched “Nikkos” division focused on gastroenterology and orthopedics segment2009-Launched “Adura” division focused on cardiology and diabetes segment2011-Launched “Montana” division focused on gynecology and pediatrics segment2012-Launched “Inspira” division focused on cardiology segment2014-Launched “Victus” division focused on anti-diabetes segment-Set up Assam Facility by the Company2015-Launched “Eris 2” division focused on pain management segment2016-Acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now Aprica Pharmaceuticals Private Limited)-Acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited-Acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited2017-Acquired the trademarks ‘UNION’ ‘REUNION’ and ‘BON UNION’Awards and Accreditations :2013-Awarded ‘Competitive Strategy Leadership’ award by Frost & Sullivan-Awarded ‘Emerging Companies Excellence’ award for scalability of business model and managing operational efficiencies by Business Today and Yes Bank

Read More

Eris Lifesciences Management

NamePosition
Milind TalegaonkarCompany Secretary & Compliance Officer
Krishnakumar VaidyanathanWhole Time Director & COO
View More

Eris Lifesciences FAQs

Eris Lifesciences शेयर का खरीद मूल्य 1353.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Eris Lifesciences शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Eris Lifesciences शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 42.45 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Eris Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.06 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Eris Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.49 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Eris Lifesciences का मार्केट कैप 18753.17 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Eris Lifesciences शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1910.00 और 1200.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost